Kiora PharmaceuticalsKPRX
13F holders, Q2 2024 (June 30)15holders
$4.20avg. 13F price*
At the end of Q2 2024, 15 institutions reported holding Kiora Pharmaceuticals Inc. (KPRX) in their 13F filings. The largest holders were AIGH Capital Management LLC ($1.1M), Nantahala Capital Management, LLC ($887K) and Alyeska Investment Group, L.P. ($759K).
- Company
- Kiora Pharmaceuticals Inc.
- CUSIP
- 49721T507
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $35K |
| Exits | 0 | $0 |
Ownership 15 holders
| AIGH Capital Management LLC | 0.52% | Reduce -3.6% | 255,561 | $1.1M |
| Nantahala Capital Management, LLC | 0.09% | Reduce -3.6% | 211,110 | $887K |
| Alyeska Investment Group, L.P. | 0.00% | Reduce -28.7% | 180,780 | $759K |
| ADAR1 Capital Management, LLC | 0.15% | Add +36.1% | 172,596 | $725K |
| Velan Capital Investment Management LP | 0.29% | Reduce -3.6% | 122,223 | $513K |
| Geode Capital Management, LLC | 0.00% | Add +221.1% | 13,771 | $58K |
| UBS Group AG | 0.00% | New | 8,320 | $35K |
| BlackRock Inc. | 0.00% | Reduce -3.6% | 1,606 | $7K |
| NewEdge Advisors, LLC | 0.00% | Reduce -4.6% | 22 | $92 |
| Osaic Holdings, Inc. | 0.00% | Add +430.2% | 22 | $92 |
| Bank of America Corp. | 0.00% | New | 20 | $84 |
| US Bancorp \de | 0.00% | Add +3.6% | 8 | $34 |
| Activest Wealth Management | 0.00% | New | 3 | $13 |
| JPMorgan Chase & Co. | 0.00% | Add +116.9% | 1 | $4 |
| Morgan Stanley | 0.00% | Add +8.4% | 1 | $4 |
"% of holder's portfolio" is KPRX's weight in each manager's 13F, not the share of Kiora Pharmaceuticals Inc. the manager owns.